AI assistant
ARS Pharmaceuticals, Inc. — Director's Dealing 2024
Jun 6, 2024
32159_dirs_2024-06-06_4bacc070-73f4-4ecd-9880-b31db5be76a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2024-06-04
Reporting Person: Shah Pratik (N/A)
Reporting Person: Pratik Shah Living Trust dated June 15, 2011 (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-04 | Common Stock | J | 2665800 | — | Disposed | 7490404 | Indirect |
| 2024-06-04 | Common Stock | G | 1332900 | — | Disposed | 6157504 | Indirect |
| 2024-06-04 | Common Stock | G | 1332900 | — | Acquired | 1332900 | Indirect |
Footnotes
F1: The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1 (the "Light Trust"), of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1 (the "Star Trust"), of which an adult son of Dr. Shah is a beneficiary. Dr. Shah is grantor of The Light Trust and the Star Trust and therefore has the ability to terminate each trust. Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust.
F2: Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011.
F3: This transaction involved the reporting person's gift to his spouse.